A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects

Recently identified interleukin-28 and -29 belong to a novel type III interferon (IFN) family, which could have distinct biological properties from type I and II IFNs. Type I IFNs, IFN-α/β, have been clinically applied for treating a certain kind of malignancies for over 30 years, but a wide range o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagawa, Masatoshi, Kawamura, Kiyoko, Li, Quanhai, Tada, Yuji, Hiroshima, Kenzo, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195555/
https://www.ncbi.nlm.nih.gov/pubmed/22013482
http://dx.doi.org/10.1155/2011/479013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195555/
https://www.ncbi.nlm.nih.gov/pubmed/22013482
http://dx.doi.org/10.1155/2011/479013

Ejemplares similares